Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GS +2.5%, WAFD +1.3%
Select Index ETFs showing strength:
- QQQ +1.8%, SPY +1.6%, IWM +1.2%, DIA +1.1%
Other news:
- THRD +37.9% (announces plan of liquidation and dissolution; Initial distribution expected in the range between approximately $246.6 million and $255.4 million, or approximately $5.13-5.33/share of common stock)
- THTX +23.2% (Soleus Capital issues letter to the Board of Theratechnologies)
- TMC +20% (President Trump plans to stockpile deep-sea critical metals to counter China)
- MP +13.5% (President Trump plans to stockpile deep-sea critical metals to counter China)
- VERV +13.5% (announces positive initial data from the Heart-2 phase 1b clinical trial of VERVE-102, an in vivo base editing medicine targeting PCSK9)
- BBY +7.9% (President Trump's administration exempted items from reciprocal tariffs including smartphones, storage devices and some other electronics)
- BKD +7.1% (initiates search for new CEO, appoints interim CEO; sees Q1 Adj EBITDA exceeding expectations)
- AAPL +5.6% (President Trump's administration exempted items from reciprocal tariffs including smartphones, storage devices and some other electronics)
- PLTR +3.6% (positive Barron's article)
- INTC +3.3% (will soon announce deal to sell Altera to Silver Lake, according to Bloomberg)
- KROS +2.3% (ADAR1 Capital Management discloses 13.29% active stake; intends to have a dialog with the Issuer's management)
- XOM +2.1% (positive Barron's article)
- IDYA +2.1% (FDA Type D meeting on Phase 3 registrational trial design for darovasertib as neoadjuvant therapy for primary uveal melanoma)
- AMAT +2% (positive Barron's article)
- AMZN +1.8% (positive Barron's article)
- TSLA +1.8% (positive Barron's article)
- CVX +1.8% (positive Barron's article)
- SPGI +1.6% (S&P Global and CME Group to sell OSTTRA to KKR for $3.1 bln; expected to close in the second half of 2025)